Stratification – Page 26 – Communicable Diseases Research

ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial

Letter

Published on 2020-07-022022-10-29
Journal: Trials [Category] Coronavirus, SARS,

Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial

Letter

Published on 2020-06-102022-10-29
Journal: Trials [Category] Coronavirus, SARS,

[키워드] 1:1 Administered age antibiotic antiviral efficacy Asthma Azithromycin Beta blocker blinded block calcium cardiovascular change changed chronic clinical combination therapy Control control group coordinator COPD COVID-19 COVID-19 test Day days alive death derivative Diagnosis Direct Current discharged disorder dissemination double-blind study ECG element ergot alkaloid expected Final FiO2 generate Glucose glucose-6-phosphate dehydrogenase deficiency guide hearing loss hematological hospital hospitalisation Hospitalization hospitals Hydroxychloroquine hypersensitivity impede Inclusion Informed consent intensive care Interstitial lung disease Intervention intervention group invasive ventilation investigated investigator Liver disease lung maculopathy medication mental illness modulation myasthenia gravis negative pregnancy test network Neurogenic neurological number objective offered outcome parallel group participant Patient patients with COVID-19 Placebo pregnant Primary outcome problem protocol psoriasis pulmonary QTc QTc interval randomisation randomised randomised controlled trial receive recruited recruitment reduce Registered reported respiratory infections retinopathy risk Sample size sequence significantly Sponsor Standard standard care standard treatment status Stratification Study protocol the patient therapy treated Treatment Trial Visual field website women
[DOI] 10.1186/s13063-020-04409-9 PMC 바로가기 [Article Type] Letter

A pilot study of therapeutic plasma exchange for serious SARS CoV-2 disease (COVID-19): A structured summary of a randomized controlled trial study protocol

Letter

Published on 2020-06-082022-10-29
Journal: Trials [Category] COVID-19, SARS,

[키워드] 1:1 24 hour 28-day mortality activated acute respiratory distress syndrome Administered Admission adverse effect age albumin allergic allocation concealment Anticoagulant apheresis approval approved assessment Basel block size C-reactive protein category changes in city Coagulopathy Control COVID-19 COVID-19 disease criteria Cytokine release syndrome D-dimer defined disease dissemination drug eight element Enrollment evaluate evaluated ferritin fibrinogen first dose FIVE food function group ICU ICU admission ill patient Improving Inc. Inflammatory ingredient intensive care intensive care unit International Intervention intervention group intubation IRB ISRCTN KDIGO King Kingdom Laboratory lack lactate dehydrogenase life threatening life-threatening Life-threatening COVID-19 marker measure Mild Ministry of Health Multicenter trial Multisystem organ failure National negative RT-PCR normalized number objective occur on mechanical ventilation Open-label outcome Palliative care participant Participants Patient patients performed pilot study plasma primary site Prothrombin time protocol Qiagen randomization randomize Randomized Randomized controlled trial randomized trial Real-time PCR receive receiving recommendations recruit reduce replaced Roche RT-PCR RT-PCR kit Safety Sample size SARS CoV-2 SARS-CoV-2 SARS-COV-2 infection Saudi Arabia secondary serum Seven sodium SOFA status Stratification Study protocol supportive care Switzerland System Therapeutic plasma exchange therapy TPE treatment for COVID-19 tumor necrosis factor-alpha USA Volume website
[DOI] 10.1186/s13063-020-04454-4 PMC 바로가기 [Article Type] Letter

COVID-19 and the role of chronic inflammation in patients with obesity

Research

Published on 2020-05-142022-10-05
Journal: International journal of obesity (2005) [Category] SARS, 바이오마커,

[키워드] acute respiratory syndrome Affect all-cause mortality amplify Atherosclerosis BMI body mass index C-reactive protein (CRP chronic inflammation chronic systemic inflammation Comorbidity Complication condition coronavirus Coronavirus disease 2019 COVID-19 Edmonton functional Hospitalization hyperinflammation hypertension ill patient immune response Immunosuppression impair IMPROVE Infection interleukin-6 Linear regression analysis Mental Mortality obesity outcome patients with COVID-19 patients with obesity physician positive correlation pro-inflammatory response Respiratory Support risk SARS-CoV-2 shown Stage staging Stratification System therapy type 2 diabetes WHR
[DOI] 10.1038/s41366-020-0597-4 [Article Type] Research

Rational and practical use of imaging in COVID-19 pneumonia

View Point

Published on 2020-05-012022-10-29
Journal: Pakistan Journal of Medical Sciences [Category] COVID-19,

A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic Coronavirus Disease 2019 (COVID-19)

Infectious Disease

Published on 2020-04-062022-10-31
Journal: Cureus [Category] COVID-19,

[키워드] ACE ACE2 Angiotensin-converting enzyme ARDS Basic science Biochemistry can be used candidate CDC center Chloroquine clinical Clinical course Clinical practice clinical trial Comprehensive Control Coronavirus disease 2019 Corticosteroid COVID-19 COVID19 described diagnostic discharge disease course epidemiological evaluate evaluated Evolution experiment explain Factor Frequency global pandemic H1N1 hindrance hospital ibuprofen Infection information inhibitors limitation literature literature review LOPINAVIR AND RITONAVIR management manuscript media MERS Micronutrient mRNA-1273 vaccine multiple parameter nonsteroidal anti-inflammatory drug NSAIDS outbreak pandemic Phylogeny presentation Prophylaxis Public health interventions remdesivir (GS-5734) review risk factor SARS-CoV-2 self-quarantine severe acute respiratory infection Spread statistical Stratification Symptom the SARS-CoV-2 virus the WHO therapy Treatment viral genome virion Vitamin C
[DOI] 10.7759/cureus.7560 PMC 바로가기 [Article Type] Infectious Disease

Primary stratification and identification of suspected Corona virus disease 2019 (COVID-19) from clinical perspective by a simple scoring proposal

Commentary

Published on 2020-04-042022-10-31
Journal: Military Medical Research [Category] COVID-19, Fulltext, SARS,

Applied mathematical modelling to inform national malaria policies, strategies and operations in Tanzania

탄자니아의 국가 말라리아 정책, 전략 및 운영을 알리기 위해 응용 수학 모델링을 적용했습니다.

Case Study

Published on 2020-03-022024-08-11
Journal: Malaria Journal [Category] 말라리아,

[키워드] malaria Mathematical modelling strategic planning Stratification Tanzania
[DOI] 10.1186/s12936-020-03173-0 PMC 바로가기 [Article Type] Case Study

Rationale and design of the “Tocilizumab in patients with moderate to severe COVID-19: an open-label multicentre randomized controlled” trial (TOCIBRAS)

"중등도에서 중증의 COVID-19 환자에 대한 토실리주맙: 공개 라벨 다기관 무작위 통제" 시험(TOCIBRAS)의 근거 및 설계

Original Article

Published on 2020-01-012022-08-13
Journal: Revista Brasileira de Terapia Intensiva [Category] 임상,

[키워드] 7-point ordinal scale adjusted age and sex alleviate Analysis anti-inflammatory therapies Anti-inflammatory therapy applied approved Brazil C reactive protein Clinical outcome clinical outcomes clinical status combating consequence Coronavírus COVID-19 COVID-19 patient COVID-19 patients criteria D-dimer disease severity dissemination enrolment ethical committee Ethics ferritin IMPROVE inflammatory cascade inflammatory mediator Inflammatory response inhibiting institutional review board institutional review boards interleukin-6 International Lactate lactate dehydrogenase limit Local mediator moderate to severe multicentre National Odds ratio Open-label ordinal logistic regression Ordinal Scale outcome patients patients with COVID-19 patients with moderate primary endpoint Pro-inflammatory marker pro-inflammatory markers protocol Randomized Randomized controlled trial rationale required severe COVID-19 severity Standard of care Stratification Study protocol the disease The TOCIBRAS protocol TOCIBRAS Tocilizumab Tocilizumabe Trial trial testing variable
[DOI] 10.5935/0103-507X.20200060 PMC 바로가기 [Article Type] Original Article

Improved spatial ecological sampling using open data and standardization: an example from malaria mosquito surveillance

개방 데이터와 표준화를 활용한 향상된 공간 생태 샘플링: 말라리아 모기 감시의 사례

Article

Published on 2019-04-102024-08-11
Journal: Journal of the Royal Society Interface [Category] 말라리아,

[키워드] adaptive and non-adaptive sampling design model-based geostatistics Mosquito sampling remote sensing and field data Stratification sub-Saharan Africa
[DOI] 10.1098/rsif.2018.0941 PMC 바로가기